Press release


19/02/2014
Biotech Development sets up its offices at the Parc Científic de Barcelona
Miguel García Soria, CEO de Biotech Development. © Parc Científic de Barcelona

Biotech Development, a consultancy company specializing in R&D+i, knowledge transfer and development of postgraduate training programs has just moved its headquarters to the Parc Científic de Barcelona. The startup wants to strengthen its business model and public-private collaborative partnerships to enhance its expansion strategy in the field of biotechnology.
 
Biotech Development was created in 2013 by 27-year old enterprising young biologist by the name of Juan Garcia Soria, in response to a clear need in the Spanish biotechnology sector: bridging the gap for effective and dynamic communication between the academia and the industry and generate new public-private collaboration partnerships so that the results of research in health sciences are transferred to the marked as economic realities and new drugs for the benefit of society.

"Contributing to the value chain of the development process of new drugs by investing in its most valuable asset, the human asset, has been the leitmotiv for creating Biotech Development," said Juan Garcia Soria, the startup CEO."In the reality of current research we face two distinct challenges: first, to promote knowledge transfer and public-private collaborative partnerships and, secondly, to support professionals in the life sciences to take on the process of change that is involved and to provide business solutions for the funding of new lines of research, "stated the young entrepreneur.

To carry out the project, the company is staffed with highly qualified multidisciplinary team and a group of investment partners with scientific and business knowledge that provide the necessary tools to address this knowledge transfer in the most effective manner. The company also has the support of institutions such as the University of Barcelona, Biocat and the Spanish Association of Biotechnology Companies (ASEBIO).

Currently, Biotech Development diversifies its activities into three distinct business lines: R&D+i Consulting, Knowledge Transfer and Business School.

R+D+i Consulting

As a company of advanced consulting services, Biotech Development offers comprehensive advice for the creation and management of biotech start-ups, promotion and development of R+D+i, licensing contracts, patent applications and other issues relating to protection and exploitation of intellectual property rights. The firm also provides strategic solutions around the creation, launch and product positioning as a basis for biotechnology based companies.

Knowledge Transfer

Biotech Development also works in the elaboration of plans for the implementation of the entire transfer process and is positioned as a partner of knowledge-generating centers with the aim of obtaining funding for new research lines. Its final client are biotech companies or pharmaceutical industry companies that conduct the clinical phase and invest in product development through commercialization.

Biotech Development Business School

Through its strategic area, Biotech Development Business School and the collaboration from ESEI International Business School, the company also develops postgraduate training programs in order to enhance mixed scientific profiles capable of transforming a research project into a business reality. As a business school, it has created, taught, and managed its own Masters and a postgraduate course (specific degrees of the University of Barcelona): Masters in Applied Research and Knowledge Transfer in Biomedicine and Healthcare Biotechnology and a Postgraduate Diploma in Scientific Management and a Postgraduate Diploma in Scientific Management: Management and Professional Development the field of biomedicine and healthcare biotechnology.




 
 
Related links:
 
 
Permalink  
 
Developed by Web4Bio